Abnormal histone methylation is responsible for increased vascular endothelial growth factor 165a secretion from airway smooth muscle cells in asthma

Journal of Immunology

Volumn 189, Issue 2, 2012, Pages 819-831

  Clifford, Rachel L ^a   John, Alison E ^a   Brightling, Christopher E ^b   Knox, Alan J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; ISOPROTEIN; LYSINE; MESSENGER RNA; RNA POLYMERASE II; TATA BINDING PROTEIN ASSOCIATED FACTOR; TATA BINDING PROTEIN ASSOCIATED FACTOR 1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 165A;

ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA METHYLATION; GENE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; HISTONE METHYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; VEGF GENE;

AIRWAY REMODELING; ASTHMA; BRONCHI; CELLS, CULTURED; DNA METHYLATION; HISTONES; HUMANS; MYOCYTES, SMOOTH MUSCLE; PROTEIN ISOFORMS; TRANSCRIPTION, GENETIC; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863611382     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103641     Document Type: Article

References (67)

1. Kazi, A. S., S. Lotfi, E. A. Goncharova, O. Tliba, Y. Amrani, V. P. Krymskaya, and A. L. Lazaar. 2004. Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L539-L545. (Pubitemid 38233625)
2. McDonald, D. M. 2001. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am. J. Respir. Crit. Care Med. 164: S39-S45.
3. Lee, S. Y., S. Kwon, K. H. Kim, H. S. Moon, J. S. Song, S. H. Park, and Y. K. Kim. 2006. Expression of vascular endothelial growth factor and hypoxiainducible factor in the airway of asthmatic patients. Ann. Allergy Asthma Immunol. 97: 794-799. (Pubitemid 46032432)
4. Asai, K., H. Kanazawa, H. Kamoi, S. Shiraishi, K. Hirata, and J. Yoshikawa. 2003. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin. Exp. Allergy 33: 595-599. (Pubitemid 36629683)
5. Siddiqui, S., A. Sutcliffe, A. Shikotra, L. Woodman, C. Doe, S. McKenna, A. Wardlaw, P. Bradding, I. Pavord, and C. Brightling. 2007. Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis. J. Allergy Clin. Immunol. 120: 813-819. (Pubitemid 47531832)
6. Dunnill, M. S., G. R. Massarella, and J. A. Anderson. 1969. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax 24: 176-179.
7. Clifford, R. L., W. R. Coward, A. J. Knox, and A. E. John. 2011. Transcriptional regulation of inflammatory genes associated with severe asthma. Curr. Pharm. Des. 17: 653-666.
8. Simcock, D. E., V. Kanabar, G. W. Clarke, K. Mahn, C. Karner, B. J. O'Connor, T. H. Lee, and S. J. Hirst. 2008. Induction of angiogenesis by airway smooth muscle from patients with asthma. Am. J. Respir. Crit. Care Med. 178: 460-468.
9. Pagès, G., and J. Pouysségur. 2005. Transcriptional regulation of the Vascular Endothelial Growth Factor gene - a concert of activating factors. Cardiovasc. Res. 65: 564-573. (Pubitemid 40138977)
10. Clifford, R. L., K. Deacon, and A. J. Knox. 2008. Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (β)1: requirement for Smads, (β)-CATENIN, AND GSK3(β). J. Biol. Chem. 283: 35337-35353.
11. Jung, H. J., H. J. Kang, Y. S. Song, E. H. Park, Y. M. Kim, and C. J. Lim. 2008. Anti-inflammatory, anti-angiogenic and anti-nociceptive activities of Sedum sarmentosum extract. J. Ethnopharmacol. 116: 138-143.
12. Lopes, F. L., J. Desmarais, S. Ledoux, N. Y. Gévry, P. Lefevre, and B. D. Murphy. 2006. Transcriptional regulation of uterine vascular endothelial growth factor during early gestation in a carnivore model, Mustela vison. J. Biol. Chem. 281: 24602-24611. (Pubitemid 44274234)
13. Ziel, K. A., C. C. Campbell, G. L. Wilson, and M. N. Gillespie. 2004. Ref-1/Ape is critical for formation of the hypoxia-inducible transcriptional complex on the hypoxic response element of the rat pulmonary artery endothelial cell VEGF gene. FASEB J. 18: 986-988. (Pubitemid 39561500)
14. Jung, J. E., H. G. Lee, I. H. Cho, D. H. Chung, S. H. Yoon, Y. M. Yang, J. W. Lee, S. Choi, J. W. Park, S. K. Ye, et al. 2005. STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J. 19: 1296-1298. (Pubitemid 41113728)
15. Cedar, H., and Y. Bergman. 2009. Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 10: 295-304.
16. Yoo, P. S., A. L. Mulkeen, and C. H. Cha. 2006. Post-transcriptional regulation of vascular endothelial growth factor: implications for tumor angiogenesis. World J. Gastroenterol. 12: 4937-4942. (Pubitemid 44323260)
17. Liu, L., and M. C. Simon. 2004. Regulation of transcription and translation by hypoxia. Cancer Biol. Ther. 3: 492-497. (Pubitemid 41351114)
18. Rennel, E. S., A. H. Varey, A. J. Churchill, E. R. Wheatley, L. Stewart, S. Mather, D. O. Bates, and S. J. Harper. 2009. VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. Br. J. Cancer 101: 1183-1193.
19. Kawamura, H., X. Li, S. J. Harper, D. O. Bates, and L. Claesson-Welsh. 2008. Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity. Cancer Res. 68: 4683-4692.
20. Woolard, J., W. Y. Wang, H. S. Bevan, Y. Qiu, L. Morbidelli, R. O. Pritchard-Jones, T. G. Cui, M. Sugiono, E. Waine, R. Perrin, et al. 2004. VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 64: 7822-7835. (Pubitemid 39446915)
21. Bradbury, D., D. Clarke, C. Seedhouse, L. Corbett, J. Stocks, and A. Knox. 2005. Vascular endothelial growth factor induction by prostaglandin E2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SP-1 transcription factor binding sites. J. Biol. Chem. 280: 29993-30000. (Pubitemid 41216174)
22. Kaur, D., R. Saunders, P. Berger, S. Siddiqui, L. Woodman, A. Wardlaw, P. Bradding, and C. E. Brightling. 2006. Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma. Am. J. Respir. Crit. Care Med. 174: 1179-1188. (Pubitemid 44924818)
23. Kaur, D., F. Hollins, R. Saunders, L. Woodman, A. Sutcliffe, G. Cruse, P. Bradding, and C. Brightling. 2010. Airway smooth muscle proliferation and survival is not modulated by mast cells. Clin. Exp. Allergy 40: 279-288.
24. Knox, A. J., L. Corbett, J. Stocks, E. Holland, Y. M. Zhu, and L. Pang. 2001. Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism. FASEB J. 15: 2480-2488. (Pubitemid 33063176)
25. Miller-Kasprzak, E., and P. P. Jagodziński. 2008. 5-Aza-2′-deoxycytidine increases the expression of anti-angiogenic vascular endothelial growth factor 189b variant in human lung microvascular endothelial cells. Biomed. Pharmacother. 62: 158-163. (Pubitemid 351381933)
26. Al-Sarraj, A., R. M. Day, and G. Thiel. 2005. Specificity of transcriptional regulation by the zinc finger transcription factors Sp1, Sp3, and Egr-1. J. Cell. Biochem. 94: 153-167. (Pubitemid 41420333)
27. Gyory, I., J. Wu, G. Fejér, E. Seto, and K. L. Wright. 2004. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat. Immunol. 5: 299-308. (Pubitemid 38332127)
28. Melcher, M., M. Schmid, L. Aagaard, P. Selenko, G. Laible, and T. Jenuwein. 2000. Structure-function analysis of SUV39H1 reveals a dominant role in heterochromatin organization, chromosome segregation, and mitotic progression. Mol. Cell. Biol. 20: 3728-3741.
29. Ferrara, N., H. P. Gerber, and J. LeCouter. 2003. The biology of VEGF and its receptors. Nat. Med. 9: 669-676. (Pubitemid 36749215)
30. Bates, D. O., T. G. Cui, J. M. Doughty, M. Winkler, M. Sugiono, J. D. Shields, D. Peat, D. Gillatt, and S. J. Harper. 2002. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res. 62: 4123-4131. (Pubitemid 34791084)
31. Tan, N. Y., and L. M. Khachigian. 2009. Sp1 phosphorylation and its regulation of gene transcription. Mol. Cell. Biol. 29: 2483-2488.
32. Cho, S. G., Z. Yi, X. Pang, T. Yi, Y. Wang, J. Luo, Z. Wu, D. Li, and M. Liu. 2009. Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation. Cancer Res. 69: 7062-7070.
33. Song, Y., J. Wu, R. A. Oyesanya, Z. Lee, A. Mukherjee, and X. Fang. 2009. Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism. Clin. Cancer Res. 15: 492-501.
34. Prasanna Kumar, S., G. Thippeswamy, M. L. Sheela, B. T. Prabhakar, and B. P. Salimath. 2008. Butyrate-induced phosphatase regulates VEGF and angiogenesis via Sp1. Arch. Biochem. Biophys. 478: 85-95.
35. Santra, M., S. Santra, J. Zhang, and M. Chopp. 2008. Ectopic decorin expression up-regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1a, and Stat3. J. Neurochem. 105: 324-337. (Pubitemid 351492476)
36. Loeffler, S., B. Fayard, J. Weis, and J.Weissenberger. 2005. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int. J. Cancer 115: 202-213. (Pubitemid 40586728)
37. Blume, S. W., R. C. Snyder, R. Ray, S. Thomas, C. A. Koller, and D. M. Miller. 1991. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J. Clin. Invest. 88: 1613-1621.
38. Hilton, T. L., Y. Li, E. L. Dunphy, and E. H. Wang. 2005. TAF1 histone acetyltransferase activity in Sp1 activation of the cyclin D1 promoter. Mol. Cell. Biol. 25: 4321-4332. (Pubitemid 40617676)
39. Abdelrahim, M., and S. Safe. 2005. Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. Mol. Pharmacol. 68: 317-329. (Pubitemid 41058295)
40. Faffe, D. S., L. Flynt, K. Bourgeois, R. A. Panettieri, Jr., and S. A. Shore. 2006. Interleukin-13 and interleukin-4 induce vascular endothelial growth factor release from airway smooth muscle cells: role of vascular endothelial growth factor genotype. Am. J. Respir. Cell Mol. Biol. 34: 213-218. (Pubitemid 43202468)
41. Tang, S. C., M. F. Wu, R. H. Wong, Y. F. Liu, L. C. Tang, C. H. Lai, C. P. Hsu, and J. L. Ko. 2011. Epigenetic mechanisms for silencing glutathione S-transferase m2 expression by hypermethylated specificity protein 1 binding in lung cancer. Cancer 117: 3209-3221.
42. Wu, S. C., and Y. Zhang. 2010. Active DNA demethylation: many roads lead to Rome. Nat. Rev. Mol. Cell Biol. 11: 607-620.
43. Mancarelli, M. M., F. Zazzeroni, L. Ciccocioppo, D. Capece, A. Po, S. Murgo, R. Di Camillo, C. Rinaldi, E. Ferretti, A. Gulino, et al. 2010. The tumor suppressor gene KCTD11REN is regulated by Sp1 and methylation and its expression is reduced in tumors. Mol. Cancer 9: 172.
44. Douet, V., M. B. Heller, and O. Le Saux. 2007. DNA methylation and Sp1 binding determine the tissue-specific transcriptional activity of the mouse Abcc6 promoter. Biochem. Biophys. Res. Commun. 354: 66-71. (Pubitemid 46123201)
45. Zhang, D., D. Ai, H. Tanaka, B. D. Hammock, and Y. Zhu. 2010. DNA methylation of the promoter of soluble epoxide hydrolase silences its expression by an SP-1-dependent mechanism. Biochim. Biophys. Acta 1799: 659-667.
46. Denissov, S., M. van Driel, R. Voit, M. Hekkelman, T. Hulsen, N. Hernandez, I. Grummt, R. Wehrens, and H. Stunnenberg. 2007. Identification of novel functional TBP-binding sites and general factor repertoires. EMBO J. 26: 944-954.
47. Kumar, P., R. Garg, G. Bolden, and K. N. Pandey. 2010. Interactive roles of Ets-1, Sp1, and acetylated histones in the retinoic acid-dependent activation of guanylyl cyclase/atrial natriuretic peptide receptor-A gene transcription. J. Biol. Chem. 285: 37521-37530.
48. Li, Y., T. Kimura, R. W. Huyck, J. H. Laity, and G. K. Andrews. 2008. Zincinduced formation of a coactivator complex containing the zinc-sensing transcription factor MTF-1, p300/CBP, and Sp1. Mol. Cell. Biol. 28: 4275-4284. (Pubitemid 351904950)
49. Lim, S., E. Metzger, R. Schüle, J. Kirfel, and R. Buettner. 2010. Epigenetic regulation of cancer growth by histone demethylases. Int. J. Cancer 127: 1991-1998.
50. Giacca, M. 2010. Non-redundant functions of the protein isoforms arising from alternative splicing of the VEGF-A pre-mRNA. Transcription 1: 149-153.
51. Shimoyamada, H., T. Yazawa, H. Sato, K. Okudela, J. Ishii, M. Sakaeda, K. Kashiwagi, T. Suzuki, H. Mitsui, T. Woo, et al. 2010. Early growth response-1 induces and enhances vascular endothelial growth factor-A expression in lung cancer cells. Am. J. Pathol. 177: 70-83.
52. Golay, J., L. Cuppini, F. Leoni, C. Micò, V. Barbui, M. Domenghini, L. Lombardi, A. Neri, A. M. Barbui, A. Salvi, et al. 2007. The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells. Leukemia 21: 1892-1900. (Pubitemid 47299961)
53. Chen, S., B. Feng, B. George, R. Chakrabarti, M. Chen, and S. Chakrabarti. 2010. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. Am. J. Physiol. Endocrinol. Metab. 298: E127-E137.
54. Groner, A. C., S. Meylan, A. Ciuffi, N. Zangger, G. Ambrosini, N. Dénervaud, P. Bucher, and D. Trono. 2010. KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading. PLoS Genet. 6: e1000869.
55. Strunnikova, M., U. Schagdarsurengin, A. Kehlen, J. C. Garbe, M. R. Stampfer, and R. Dammann. 2005. Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter. Mol. Cell. Biol. 25: 3923-3933. (Pubitemid 40617644)
56. Sun, D., W. J. Liu, K. Guo, J. J. Rusche, S. Ebbinghaus, V. Gokhale, and L. H. Hurley. 2008. The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex-interactive agents. Mol. Cancer Ther. 7: 880-889. (Pubitemid 351551041)
57. Deng, Z., J. Norseen, A. Wiedmer, H. Riethman, and P. M. Lieberman. 2009. TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol. Cell 35: 403-413.
58. Nagano, T., J. A. Mitchell, L. A. Sanz, F. M. Pauler, A. C. Ferguson-Smith, R. Feil, and P. Fraser. 2008. The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 322: 1717-1720.
59. Bousquet, J., P. K. Jeffery, W. W. Busse, M. Johnson, and A. M. Vignola. 2000. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161: 1720-1745. (Pubitemid 30329053)
60. Li, X., and J. W. Wilson. 1997. Increased vascularity of the bronchial mucosa in mild asthma. Am. J. Respir. Crit. Care Med. 156: 229-233. (Pubitemid 27293194)
61. Hashimoto, M., H. Tanaka, and S. Abe. 2005. Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. Chest 127: 965-972. (Pubitemid 40775530)
62. Kanazawa, H., K. Hirata, and J. Yoshikawa. 2002. Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients. Thorax 57: 885-888. (Pubitemid 35178614)
63. Kanazawa, H., S. Nomura, and J. Yoshikawa. 2004. Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis. Am. J. Respir. Crit. Care Med. 169: 1125-1130. (Pubitemid 38624792)
64. Feltis, B. N., D. Wignarajah, L. Zheng, C. Ward, D. Reid, R. Harding, and E. H. Walters. 2006. Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. Am. J. Respir. Crit. Care Med. 173: 1201-1207. (Pubitemid 43848389)
65. Simcock, D. E., V. Kanabar, G. W. Clarke, B. J. O'Connor, T. H. Lee, and S. J. Hirst. 2007. Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. Am. J. Respir. Crit. Care Med. 176: 146-153. (Pubitemid 47057850)
66. Abdel-Rahman, A. M., S. A. el-Sahrigy, and S. I. Bakr. 2006. A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack. Chest 129: 266-271. (Pubitemid 43289843)
67. Plumb, J. A., N. Steele, P. W. Finn, and R. Brown. 2004. Epigenetic approaches to cancer therapy. Biochem. Soc. Trans. 32: 1095-1097. (Pubitemid 39655556)